Discovery Chronic devision lacking service and poor response time

MailRef#***#-

The saga regarding funding for essential blood thinning medication not fully resolved and is dated back to November 2022. I have received a letter from Discovery in May 2024 that fundling for Rivaxored was approved. However, at the Pharmacy a large co-payment was due. When I queried same with Discovery the statement was made that the Pharmacy issued Rezalto and the approval is only valid for Rivaxored. So, in June I took the letter to the Pharmacy and it appeared that Rivaxored was withdrawn in South Africa. I contacted the very helpful lady at Discovery again (Aphiwe) I was for the very first time impressed with the service as Aphiwe arranged a new approval this time for the generic (Rezalto) However it was only approved as a once off pending proof that Rivaxored was indeed not available in South Africa. I was planning to report this prompt and efficient service on Hellopeter, but then decided to hang on until I get a new approval letter. I have obtained the proof and submitted it to Discovery on 4 July 2024.So this is where the good service stopped again. On 12 July I requested feedback, Discovery feedback that they waiting on the proof that was requested. (Unbelieveable) I then submitted the proof again. Once again, no response. Nearly time to collect medication again, hence my complaint to Hellopeter.